These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 28558091)

  • 61. Women's Use of Long-Acting Reversible Contraception for Birth Timing and Birth Stopping.
    Eeckhaut MCW; Rendall MS; Zvavitch P
    Demography; 2021 Aug; 58(4):1327-1346. PubMed ID: 34251428
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Factors influencing use of long-acting versus short-acting contraceptive methods among reproductive-age women in a resource-limited setting.
    Tibaijuka L; Odongo R; Welikhe E; Mukisa W; Kugonza L; Busingye I; Nabukalu P; Ngonzi J; Asiimwe SB; Bajunirwe F
    BMC Womens Health; 2017 Apr; 17(1):25. PubMed ID: 28376779
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Providing Long-acting Reversible Contraception to Adolescents: A Review.
    Bahar YZ; Gold MA
    Clin Obstet Gynecol; 2020 Sep; 63(3):561-573. PubMed ID: 32452845
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Promotion of Long-Acting Reversible Contraception Among Adolescents and Young Adults.
    Santibenchakul S; Tschann M; Carlson ADP; L Hurwitz E; Salcedo J
    J Midwifery Womens Health; 2019 Mar; 64(2):194-200. PubMed ID: 30570219
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cost as a barrier to long-acting reversible contraceptive (LARC) use in adolescents.
    Eisenberg D; McNicholas C; Peipert JF
    J Adolesc Health; 2013 Apr; 52(4 Suppl):S59-63. PubMed ID: 23535059
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The relationship between long-acting reversible contraception and insurance coverage: a retrospective analysis.
    Broecker J; Jurich J; Fuchs R
    Contraception; 2016 Mar; 93(3):266-72. PubMed ID: 26577755
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Obstetrician-gynecologists and contraception: long-acting reversible contraception practices and education.
    Luchowski AT; Anderson BL; Power ML; Raglan GB; Espey E; Schulkin J
    Contraception; 2014 Jun; 89(6):578-83. PubMed ID: 24656553
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Adolescents' Acceptance of Long-Acting Reversible Contraception After an Educational Intervention in the Emergency Department: A Randomized Controlled Trial.
    Vayngortin T; Bachrach L; Patel S; Tebb K
    West J Emerg Med; 2020 Apr; 21(3):640-646. PubMed ID: 32421513
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Projections and opinions from 100 experts in long-acting reversible contraception.
    Foster DG; Barar R; Gould H; Gomez I; Nguyen D; Biggs MA
    Contraception; 2015 Dec; 92(6):543-52. PubMed ID: 26515195
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Contraceptive care for adolescents.
    Whitaker AK; Gilliam M
    Clin Obstet Gynecol; 2008 Jun; 51(2):268-80. PubMed ID: 18463458
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A Qualitative Study of Factors That Influence Contraceptive Choice among Adolescent School-Based Health Center Patients.
    Hoopes AJ; Gilmore K; Cady J; Akers AY; Ahrens KR
    J Pediatr Adolesc Gynecol; 2016 Jun; 29(3):259-64. PubMed ID: 26477942
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Advanced Practice Registered Nurses and Long-Acting Reversible Contraception.
    Kelly PJ; Cheng AL; Carlson K; Witt J
    J Midwifery Womens Health; 2017 Mar; 62(2):190-195. PubMed ID: 28340500
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Providing long-acting reversible contraception services in Seattle school-based health centers: key themes for facilitating implementation.
    Gilmore K; Hoopes AJ; Cady J; Amies Oelschlager AM; Prager S; Vander Stoep A
    J Adolesc Health; 2015 Jun; 56(6):658-65. PubMed ID: 26003582
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Contraception for Adolescents: Focusing on Long-Acting Reversible Contraceptives (LARC) to Improve Reproductive Health Outcomes.
    Kaneshiro B; Salcedo J
    Curr Obstet Gynecol Rep; 2015 Mar; 4(1):53-60. PubMed ID: 27635305
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Increasing Use of Long-Acting Reversible Contraception to Decrease Unplanned Pregnancy.
    Lotke PS
    Obstet Gynecol Clin North Am; 2015 Dec; 42(4):557-67. PubMed ID: 26598299
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Use of Long-Acting Reversible Contraception (LARC) and the Depo-Provera Shot in Adolescents.
    Itriyeva K
    Curr Probl Pediatr Adolesc Health Care; 2018 Dec; 48(12):321-332. PubMed ID: 30466840
    [TBL] [Abstract][Full Text] [Related]  

  • 77. ACOG Committee Opinion No. 735 Summary: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol; 2018 May; 131(5):947-948. PubMed ID: 29683905
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Myths and misconceptions about long-acting reversible contraception (LARC).
    Russo JA; Miller E; Gold MA
    J Adolesc Health; 2013 Apr; 52(4 Suppl):S14-21. PubMed ID: 23535052
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.
    Mavranezouli I;
    Hum Reprod; 2008 Jun; 23(6):1338-45. PubMed ID: 18372257
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Contraceptive choices of adolescents before and after the voluntary termination of pregnancy.
    Kokanalı D; Kuntay Kokanalı M; Ayhan S; Cengaver N; Özakşit G; Engin-Üstün Y
    J Obstet Gynaecol; 2019 Aug; 39(6):822-826. PubMed ID: 31010335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.